Croda International Plc
CRDA.LBasic MaterialsLSESpecialty Chemicals · Last scanned May 30, 2026
Scan Results
Daily timeframeCroda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. Valued at $4.24B, CRDA.L is a mid-cap name in its sector. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours.
Market Cap
$4.24B
Beta
0.90
P/E (TTM)
69.11
P/E (Fwd)
16.99
EPS (TTM)
$0.44
EPS (Fwd)
$1.79
ROE
2.9%
ROA
2.1%
Cash
$172.8M
Total Debt
$696.6M
Free CF
$65.9M
52W Change
-0.1%
Annual Financials
Cash vs Debt
On the balance sheet, CRDA.L has $172.8M in cash with $696.6M in obligations. The ability to service this debt comfortably depends on continued operational cash generation. Annual free cash flow of $65.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 2.9%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.1% is on the lower side, which is common in asset-heavy industries. Revenue has pulled back from $2.09B (2022) to $1.70B (2025), a 19% decline worth watching.
The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing CRDA.L.